MEKICS Co Ltd
MEKICS CO., Ltd develops and commercializes ventilators worldwide. It offers general-purpose ventilators, respiratory care devices, patient monitoring systems, pulse oximeter, central monitoring system, and high flow nasal therapy products. The company also distributes CPAP solutions that care sleep apnea syndrome and snoring. MEKICS CO., Ltd was founded in 1998 and is headquartered in Paju, Sout… Read more
MEKICS Co Ltd (058110) - Net Assets
Latest net assets as of September 2025: ₩36.34 Billion KRW
Based on the latest financial reports, MEKICS Co Ltd (058110) has net assets worth ₩36.34 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩55.71 Billion) and total liabilities (₩19.37 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩36.34 Billion |
| % of Total Assets | 65.23% |
| Annual Growth Rate | 16.06% |
| 5-Year Change | 1.42% |
| 10-Year Change | N/A |
| Growth Volatility | 272.76 |
MEKICS Co Ltd - Net Assets Trend (2015–2024)
This chart illustrates how MEKICS Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MEKICS Co Ltd (2015–2024)
The table below shows the annual net assets of MEKICS Co Ltd from 2015 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩39.18 Billion | -21.34% |
| 2023-12-31 | ₩49.81 Billion | -26.32% |
| 2022-12-31 | ₩67.61 Billion | -4.78% |
| 2021-12-31 | ₩71.00 Billion | +83.79% |
| 2020-12-31 | ₩38.63 Billion | +855.36% |
| 2019-12-31 | ₩4.04 Billion | -20.36% |
| 2018-12-31 | ₩5.08 Billion | -35.48% |
| 2017-12-31 | ₩7.87 Billion | -20.02% |
| 2016-12-31 | ₩9.84 Billion | -4.01% |
| 2015-12-31 | ₩10.25 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to MEKICS Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 316.4% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₩8.03 Billion | 20.48% |
| Other Components | ₩35.24 Billion | 89.95% |
| Total Equity | ₩39.18 Billion | 100.00% |
MEKICS Co Ltd Competitors by Market Cap
The table below lists competitors of MEKICS Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mandom Indonesia Tbk
JK:TCID
|
$14.44 Million |
|
Symphony Communication Public Company Limited
BK:SYMC
|
$14.45 Million |
|
Melbana Energy Limited
PINK:MEOAF
|
$14.46 Million |
|
Winner Group Enterprise Public Company Limited
BK:WINNER
|
$14.46 Million |
|
Hariom Pipe Industries Limited
NSE:HARIOMPIPE
|
$14.44 Million |
|
Aware Inc
NASDAQ:AWRE
|
$14.44 Million |
|
Archtis Ltd
AU:AR9
|
$14.43 Million |
|
Camimex Group JSC
VN:CMX
|
$14.42 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MEKICS Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 49,682,054,640 to 39,180,553,750, a change of -10,501,500,890 (-21.1%).
- Net loss of 10,166,077,200 reduced equity.
- Share repurchases of 251,002,110 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-10.17 Billion | -25.95% |
| Share Repurchases | ₩251.00 Million | -0.64% |
| Other Changes | ₩-84.42 Million | -0.22% |
| Total Change | ₩- | -21.14% |
Book Value vs Market Value Analysis
This analysis compares MEKICS Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.72x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 2.07x to 0.72x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩886.68 | ₩1832.00 | x |
| 2017-12-31 | ₩709.13 | ₩1832.00 | x |
| 2018-12-31 | ₩457.50 | ₩1832.00 | x |
| 2019-12-31 | ₩364.35 | ₩1832.00 | x |
| 2020-12-31 | ₩2670.15 | ₩1832.00 | x |
| 2021-12-31 | ₩4528.35 | ₩1832.00 | x |
| 2022-12-31 | ₩4311.81 | ₩1832.00 | x |
| 2023-12-31 | ₩3168.59 | ₩1832.00 | x |
| 2024-12-31 | ₩2528.18 | ₩1832.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MEKICS Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -25.95%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -89.42%
- • Asset Turnover: 0.19x
- • Equity Multiplier: 1.52x
- Recent ROE (-25.95%) is below the historical average (-9.27%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 25.33% | 28.85% | 0.42x | 2.12x | ₩1.57 Billion |
| 2016 | -18.13% | -22.52% | 0.32x | 2.54x | ₩-2.77 Billion |
| 2017 | -24.74% | -22.63% | 0.38x | 2.89x | ₩-2.73 Billion |
| 2018 | -53.33% | -31.03% | 0.36x | 4.81x | ₩-3.22 Billion |
| 2019 | -35.41% | -11.13% | 0.52x | 6.15x | ₩-1.84 Billion |
| 2020 | 62.53% | 35.50% | 0.96x | 1.83x | ₩20.30 Billion |
| 2021 | 13.35% | 19.23% | 0.51x | 1.36x | ₩2.38 Billion |
| 2022 | -3.95% | -9.30% | 0.33x | 1.28x | ₩-9.43 Billion |
| 2023 | -32.45% | -121.57% | 0.19x | 1.38x | ₩-21.09 Billion |
| 2024 | -25.95% | -89.42% | 0.19x | 1.52x | ₩-14.08 Billion |
Industry Comparison
This section compares MEKICS Co Ltd's net assets metrics with peer companies in the Healthcare Equipment & Supplies industry.
Industry Context
- Industry: Healthcare Equipment & Supplies
- Average net assets among peers: $101,204,146,306
- Average return on equity (ROE) among peers: -4.63%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MEKICS Co Ltd (058110) | ₩36.34 Billion | 25.33% | 0.53x | $14.44 Million |
| InBody Co.Ltd (041830) | $183.73 Billion | 18.52% | 0.11x | $208.16 Million |
| MEDIANA Co.Ltd (041920) | $34.91 Billion | 20.29% | 0.27x | $70.69 Million |
| Value Added Technology Co. Ltd (043150) | $349.29 Billion | 22.01% | 0.46x | $109.99 Million |
| Meta Biomed Co. Ltd (059210) | $39.05 Billion | 3.02% | 0.38x | $50.83 Million |
| INFINITT Healthcare Co. Ltd (071200) | $77.28 Billion | 6.38% | 0.20x | $53.10 Million |
| i-SENS Inc (099190) | $118.81 Billion | 12.18% | 0.38x | $127.37 Million |
| Sewoon Medical Co. Ltd (100700) | $46.71 Billion | 7.88% | 0.18x | $34.07 Million |
| CU Medical Systems Inc (115480) | $58.36 Billion | 16.15% | 0.51x | $14.81 Million |
| PeopleBio Inc (304840) | $2.70 Billion | -148.07% | 0.61x | $5.72 Million |